Search Results for: Gene Therapy
COVID-19 PARP Inhibitor
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
In-Depth Microbiome
Gearing Towards a Microbiome Driven Therapy for Fighting Inflammatory Diseases
2020-03-20
COVID-19
Weekly Cover : Fosun and BioNTech Invest USD 135m for Covid-19 Vaccine
2020-03-19
Trials & Approvals JAK/STAT
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
R&D PD-L1
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
COVID-19 Children
New Study Suggests How Children Might be Persistently Spreading Coronavirus
2020-03-13
COVID-19 Virus Suppressing Factor
Weekly Cover: Takeda Initiates Development of Potential COVID-19 Therapy TAK-888
2020-03-13
Trials & Approvals Lung Cancer
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Trials & Approvals Cystinosis
Investigational Gene Therapy for Cystinosis Obtains FDA’s Orphan Drug Designation
2020-03-10
Trials & Approvals PARP Inhibitor
GSK’s PARP Inhibitor, Zejula Gets Foot in the Door in EU to rival Rubraca and Lynparza
2020-03-06
Technology CRISPR
Landmark CRISPR Trial Marks First Ever Gene Editing Inside Human Body
2020-03-05
COVID-19 Favilavir
Weekly Cover: Taiwan Synthesizes Potential COVID-19 Treatment Favilavir
2020-03-04
Trials & Approvals Acute Hepatic Porphyria
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
R&D Classical Hodgkin Lymphoma
Keytruda Outcompetes Adcetris in Refractory or Relapsed Hodgkin Lymphoma Study
2020-03-03
M&A CD47
Gilead Strikes US$ 4.9B Takeover Deal of Forty Seven
2020-03-02
1 … 92 93 94 95 96 … 105
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top